355 related articles for article (PubMed ID: 28404135)
1. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study.
Islam N; Krajden M; Shoveller J; Gustafson P; Gilbert M; Buxton JA; Wong J; Tyndall MW; Janjua NZ;
Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):200-210. PubMed ID: 28404135
[TBL] [Abstract][Full Text] [Related]
2. Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies.
Sacks-Davis R; van Santen DK; Boyd A; Young J; Stewart A; Doyle JS; Rauch A; Mugglin C; Klein M; van der Valk M; Smit C; Jarrin I; Berenguer J; Lacombe K; Requena MB; Wittkop L; Leleux O; Bonnet F; Salmon D; Matthews GV; Guy R; Martin NK; Spelman T; Prins M; Stoove M; Hellard M;
Lancet HIV; 2024 Feb; 11(2):e106-e116. PubMed ID: 38224708
[TBL] [Abstract][Full Text] [Related]
3. Reinfection with hepatitis C virus following sustained virological response in injection drug users.
Grebely J; Knight E; Ngai T; Genoway KA; Raffa JD; Storms M; Gallagher L; Krajden M; Dore GJ; Duncan F; Conway B
J Gastroenterol Hepatol; 2010 Jul; 25(7):1281-4. PubMed ID: 20594256
[TBL] [Abstract][Full Text] [Related]
4. Initiating HCV treatment with direct acting agents in opioid agonist treatment: When to start for people co-infected with HIV?
Panagiotoglou D; Krebs E; Min JE; Olding M; Ahamad K; Ti L; Montaner JSG; Nosyk B
Int J Drug Policy; 2017 Sep; 47():169-176. PubMed ID: 28578865
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus reinfection in injection drug users.
Grebely J; Conway B; Raffa JD; Lai C; Krajden M; Tyndall MW
Hepatology; 2006 Nov; 44(5):1139-45. PubMed ID: 17058216
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C.
Marco A; Esteban JI; Solé C; da Silva A; Ortiz J; Roget M; Sarriera C; Teixidó N; Guerrero RA; Caylà JA
J Hepatol; 2013 Jul; 59(1):45-51. PubMed ID: 23523577
[TBL] [Abstract][Full Text] [Related]
7. HCV co-infection in HIV positive population in British Columbia, Canada.
Buxton JA; Yu A; Kim PH; Spinelli JJ; Kuo M; Alvarez M; Gilbert M; Krajden M
BMC Public Health; 2010 Apr; 10():225. PubMed ID: 20429917
[TBL] [Abstract][Full Text] [Related]
8. Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?
Lima VD; Rozada I; Grebely J; Hull M; Lourenco L; Nosyk B; Krajden M; Yoshida E; Wood E; Montaner JS
PLoS One; 2015; 10(12):e0143836. PubMed ID: 26633652
[TBL] [Abstract][Full Text] [Related]
9. Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.
Stone J; Fraser H; Lim AG; Walker JG; Ward Z; MacGregor L; Trickey A; Abbott S; Strathdee SA; Abramovitz D; Maher L; Iversen J; Bruneau J; Zang G; Garfein RS; Yen YF; Azim T; Mehta SH; Milloy MJ; Hellard ME; Sacks-Davis R; Dietze PM; Aitken C; Aladashvili M; Tsertsvadze T; Mravčík V; Alary M; Roy E; Smyrnov P; Sazonova Y; Young AM; Havens JR; Hope VD; Desai M; Heinsbroek E; Hutchinson SJ; Palmateer NE; McAuley A; Platt L; Martin NK; Altice FL; Hickman M; Vickerman P
Lancet Infect Dis; 2018 Dec; 18(12):1397-1409. PubMed ID: 30385157
[TBL] [Abstract][Full Text] [Related]
10. Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta-analysis.
Artenie A; Stone J; Fraser H; Stewart D; Arum C; Lim AG; McNaughton AL; Trickey A; Ward Z; Abramovitz D; Alary M; Astemborski J; Bruneau J; Clipman SJ; Coffin CS; Croxford S; DeBeck K; Emanuel E; Hayashi K; Hermez JG; Low-Beer D; Luhmann N; Macphail G; Maher L; Palmateer NE; Patel EU; Sacks-Davis R; Van Den Boom W; van Santen DK; Walker JG; Hickman M; Vickerman P;
Lancet Gastroenterol Hepatol; 2023 Jun; 8(6):533-552. PubMed ID: 36996853
[TBL] [Abstract][Full Text] [Related]
11. Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?
Grebely J; Dore GJ; Morin S; Rockstroh JK; Klein MB
J Int AIDS Soc; 2017 Jul; 20(1):22146. PubMed ID: 28782335
[TBL] [Abstract][Full Text] [Related]
12. All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019.
Requena MB; Protopopescu C; Stewart AC; van Santen DK; Klein MB; Jarrin I; Berenguer J; Wittkop L; Salmon D; Rauch A; Prins M; van der Valk M; Sacks-Davis R; Hellard ME; Carrieri P; Lacombe K;
Int J Drug Policy; 2024 Feb; 124():104311. PubMed ID: 38184902
[TBL] [Abstract][Full Text] [Related]
13. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review.
Larney S; Peacock A; Leung J; Colledge S; Hickman M; Vickerman P; Grebely J; Dumchev KV; Griffiths P; Hines L; Cunningham EB; Mattick RP; Lynskey M; Marsden J; Strang J; Degenhardt L
Lancet Glob Health; 2017 Dec; 5(12):e1208-e1220. PubMed ID: 29074410
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus seroprevalence among patients enrolled at the opioid substitution therapy center in Bihar: A cross-sectional study.
Kumar A; Mahajan H; Chaturvedi S; Kumar A; Kumar S; Sahoo GC; Das VNR; Pandey K
PLoS One; 2023; 18(6):e0287333. PubMed ID: 37319276
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM.
Martin TC; Martin NK; Hickman M; Vickerman P; Page EE; Everett R; Gazzard BG; Nelson M
AIDS; 2013 Oct; 27(16):2551-7. PubMed ID: 23736152
[TBL] [Abstract][Full Text] [Related]
16. Inability to access health and social services associated with mental health among people who inject drugs in a Canadian setting.
Wang L; Panagiotoglou D; Min JE; DeBeck K; Milloy MJ; Kerr T; Hayashi K; Nosyk B
Drug Alcohol Depend; 2016 Nov; 168():22-29. PubMed ID: 27610937
[TBL] [Abstract][Full Text] [Related]
17. High incidence of hepatitis C virus reinfection in a cohort of injecting drug users.
Aitken CK; Lewis J; Tracy SL; Spelman T; Bowden DS; Bharadwaj M; Drummer H; Hellard M
Hepatology; 2008 Dec; 48(6):1746-52. PubMed ID: 18844233
[TBL] [Abstract][Full Text] [Related]
18. Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
Shores NJ; Maida I; Soriano V; Núnez M
J Hepatol; 2008 Sep; 49(3):323-8. PubMed ID: 18486266
[TBL] [Abstract][Full Text] [Related]
19. A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia.
Butt ZA; Shrestha N; Wong S; Kuo M; Gesink D; Gilbert M; Wong J; Yu A; Alvarez M; Samji H; Buxton JA; Johnston JC; Cook VJ; Roth D; Consolacion T; Murti M; Hottes TS; Ogilvie G; Balshaw R; Tyndall MW; Krajden M; Janjua NZ;
PLoS One; 2017; 12(8):e0183609. PubMed ID: 28829824
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users.
Grebely J; Raffa JD; Lai C; Krajden M; Conway B; Tyndall MW
Can J Gastroenterol; 2007 Jul; 21(7):447-51. PubMed ID: 17637948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
